Latest filing published 10 Jul 2018 for Rein Therapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -28.3%Entry US$2,498.04 · Close at T+365 US$1,790.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Apple Tree Partners II - Annex, L.P.: trading record in brief
Filings by Apple Tree Partners II - Annex, L.P. span 2 companies, the busiest being Eledon Pharmaceuticals, Inc. and Rein Therapeutics, Inc. Between 22 September 2014 and 6 July 2018, the trades on record add up to 4 filings.
No open-market sale appears; the market trades are 1 purchase worth €2.8M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 10 July 2018 with a transaction in Rein Therapeutics, Inc. The last insider purchase was made public on 24 September 2014, 4,429 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Apple Tree Partners II - Annex, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 655,797 shares0Common StockSEC:0001012975-18-000907:0
- 655,797 sharesCommon StockSEC:0000899243-17-018104:0
- 3,330,938 sharesCommon StockSEC:0001209191-14-059642:0
- 237,500 shares@ US$15.00Common StockSEC:0001209191-14-059642:1Canonical exit: 21 Dec 2014 (T+90)
4 of 4 declarations
